Independent compliance consultant specialising in the review of promotional and non-promotional materials for pharmaceutical and medical device companies, including start-ups and early-stage organisations.
About us
I help pharmaceutical and medical technology companies understand and apply key UK industry and advertising codes, including the Association of the British Pharmaceutical Industry (ABPI) Code of Practice, the Association of British HealthTech Industries (ABHI) Code of Ethical Business Practice, and relevant advertising standards guidance.
With over 10 years’ experience as a medical signatory and compliance reviewer within the pharmaceutical and medtech industry, I provide structured, independent support to companies at different stages of development — including start-ups and smaller organisations that may not yet have in-house signatory or compliance expertise. I offer pragmatic reviews of promotional and non- promotional materials to help ensure materials meet UK code requirements before use, supporting both UK-based and international pharmaceutical and medical device companies operating under the ABPI and ABHI Codes.
Therapeutic experience includes work across: Oncology and Interventional Specialities; Neuroscience and Neuropsychiatry; Cardiovascular, Renal and Metabolic Conditions; Radiology and Medical Imaging; Immunology; Women’s Health; and Rare and Specialist Conditions.
Unlike legal or regulatory firms that may focus primarily on disputes, legal interpretation, or product labelling, my approach is practical and preventative. I work with teams to check that claims are accurate, responsible, and appropriately supported, helping to reduce the risk of regulatory complaints, reputational harm, or non-compliant communications.
Services
Services include compliance reviews of marketing and educational materials, advice on the use and substantiation of claims, and guidance on the practical application of relevant industry codes. My consultancy is flexible and independent, designed to support brand, medical, and commercial teams in delivering compliant and effective communications that align with UK regulatory expectations.
Support may include review of the following materials for compliance with relevant UK industry codes:
- Corporate, product and patient websites
- Digital and print promotional materials
- Educational and other non-promotional materials
- Patient support programme materials
- Market research and insight-gathering materials
- Clinical trial recruitment and research-related communications
- Sales aids, presentations, and training materials
- Social media and other digital communications
- Meeting materials for advisory boards and scientific or educational meetings
Scope of support is agreed on a project-by-project basis and does not replace internal governance processes or formal regulatory or ethics approvals where these are required.